TAUPATIAS

The TAU project (Taupatías) aims to develop innovative biomarkers based on monoclonal antibodies for the early diagnosis of neurodegenerative diseases such as Alzheimer’s Disease and Frontotemporal Dementia. These pathologies, known as tauopathies, are associated with the abnormal accumulation of the tau protein in the brain, leading to neuronal degeneration and...